C45H49N5O4
Neat
723.92
ARV-471; Vepdegestrant; ARV471; ARV-471 (protac); Arv 471; PF-07850327; PF07850327; RefChem:199635; PROTAC Protein Degrader ARV-471; ER alpha PROTAC Protein Degrader ARV-471; PF 07850327; Estrogen Receptor alpha PROTAC Protein Degrader ARV-471; ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471; 2229711-68-4; WC1U3R1YMI; (S)-3-(5-(4-((1-(4-((1R, 2S)-6-Hydroxy-2-phenyl-1, 2, 3, 4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)methyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)piperidine-2, 6-dione; (3S)-3-[5-[4-[[1-[4-[(1R, 2S)-6-hydroxy-2-phenyl-tetralin-1-yl]phenyl]-4-piperidyl]methyl]piperazin-1-yl]-1-oxo-isoindolin-2-yl]piperidine-2, 6-dione; (3S)-3-[6-[4-[[1-[4-[(1R, 2S)-6-hydroxy-2-phenyl-1, 2, 3, 4-tetrahydronaphthalen-1-yl]phenyl]piperidin-4-yl]methyl]piperazin-1-yl]-3-oxo-1H-isoindol-2-yl]piperidine-2, 6-dione; (S)-3-(5-(4-((1-(4-(rel-(1R, 2S)-6-Hydroxy-2-phenyl-1, 2, 3, 4-tetrahydronaphthalen-1-yl)phenyl)piperidin-4-yl)methyl)piperazin-1-yl)-1-oxoisoindolin-2-yl)piperidine-2 and 6-dione; 2614417-52-4
(3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl]phenyl]piperidin-4-yl]methyl]piperazin-1-yl]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione
InChI=1S/C45H49N5O4/c51-37-12-15-39-33(27-37)8-13-38(31-4-2-1-3-5-31)43(39)32-6-9-35(10-7-32)48-20-18-30(19-21-48)28-47-22-24-49(25-23-47)36-11-14-40-34(26-36)29-50(45(40)54)41-16-17-42(52)46-44(41)53/h1-7,9-12,14-15,26-27,30,38,41,43,51H,8,13,16-25,28-29H2,(H,46,52,53)/t38-,41+,43+/m1/s1